Who makes Apevinat BC?

Apevinat BC is developed by MDCPharma Produtos Farmaceuticos LTDA.

Last reviewed 2026-04-23 · How we verify

Apevinat BC

MDCPharma Produtos Farmaceuticos LTDA · Phase 3 active Small molecule

Apevinat BC's mechanism of action is currently not well-documented.

At a glance

Generic name	Apevinat BC
Also known as	MDCPharma
Sponsor	MDCPharma Produtos Farmaceuticos LTDA
Modality	Small molecule
Phase	Phase 3

Mechanism of action

There is limited information available regarding the specific molecular interactions or pathways that Apevinat BC targets.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Apevinat BC CI brief — competitive landscape report
Apevinat BC updates RSS · CI watch RSS
MDCPharma Produtos Farmaceuticos LTDA portfolio CI